Emergent BioSolutions Inc. — Director's Dealing 2020

May 19, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2020-05-14

Reporting Person: Harsanyi Zsolt (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-05-14	Common Stock	M	3434	$18.64	Acquired	28367	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-05-14	Stock Options (Right to Buy)	$18.64	M	3434	Disposed	2021-05-22	Common Stock (3434.0)	Direct

Footnotes

F1: Consists of an option granted under the company's stock incentive plan as amended and restated.

F2: Vests in three equal installments beginning on the anniversary date of the grant, 5/22/2014.